Skip to main content
FOTIVDA 1.34 mg/1 capsule by AVEO Pharmaceuticals, Inc.
FOTIVDA, 1.34 mg/1, capsule Drug class: Kinase Inhibitor. Available on prescription only. Listed by AVEO Pharmaceuticals, Inc..
Prescription only

FOTIVDA

Tivozanib

Listed by AVEO Pharmaceuticals, Inc.

Strength
1.34 mg/1
Form
Capsule
Route
Oral
Class
Kinase Inhibitor

What it contains

  • Tivozanib Hydrochloride 1.34 mg/1

FDA record

Dosage form Capsule
Route Oral
Drug class Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 45629-134
FDA application NDA212904
RxNorm concept 2534238
Package sizes listed 2
Marketed since March 2021

Other products containing Tivozanib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

FOTIVDA

Tivozanib

Strength
.89 mg/1
Form
Capsule
Class
Kinase Inhibitor
Rx only

AVEO Pharmaceuticals, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.